Triple

T11698352
Position Surface form Disambiguated ID Type / Status
Subject Lennox-Gastaut syndrome E278053 entity
Predicate treatedWith P2367 FINISHED
Object rufinamide
Rufinamide is an anticonvulsant medication primarily used to help control seizures in patients with Lennox-Gastaut syndrome.
 E939682 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: rufinamide | Statement: [Lennox-Gastaut syndrome, treatedWith, rufinamide]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: rufinamide
Context triple: [Lennox-Gastaut syndrome, treatedWith, rufinamide]
  • A. topiramate
    Topiramate is an anticonvulsant medication commonly used to treat various forms of epilepsy and prevent migraines.
  • B. lamotrigine
    Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder by stabilizing neuronal activity and reducing the frequency of seizures or mood episodes.
  • C. Namenda
    Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
  • D. carbamazepine
    Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
  • E. Epidiolex
    Epidiolex is a prescription cannabidiol-based medication used to treat certain rare and severe forms of epilepsy.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: rufinamide
Triple: [Lennox-Gastaut syndrome, treatedWith, rufinamide]
Generated description
Rufinamide is an anticonvulsant medication primarily used to help control seizures in patients with Lennox-Gastaut syndrome.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: rufinamide
Target entity description: Rufinamide is an anticonvulsant medication primarily used to help control seizures in patients with Lennox-Gastaut syndrome.
  • A. topiramate
    Topiramate is an anticonvulsant medication commonly used to treat various forms of epilepsy and prevent migraines.
  • B. lamotrigine
    Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder by stabilizing neuronal activity and reducing the frequency of seizures or mood episodes.
  • C. Namenda
    Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
  • D. carbamazepine
    Carbamazepine is an anticonvulsant and mood-stabilizing drug commonly used to treat epilepsy, trigeminal neuralgia, and bipolar disorder.
  • E. Epidiolex
    Epidiolex is a prescription cannabidiol-based medication used to treat certain rare and severe forms of epilepsy.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aafe02d881909900d54ad7d4af84 completed April 8, 2026, 7:22 p.m.
NER Named-entity recognition batch_69d8a47df68c81908a91919a69b4880d completed April 10, 2026, 7:19 a.m.
NED1 Entity disambiguation (via context triple) batch_69ef147e2e10819085eaed83fd955b6b completed April 27, 2026, 7:47 a.m.
NEDg Description generation batch_69ef3553a1748190b554463bcea8bd1d completed April 27, 2026, 10:07 a.m.
NED2 Entity disambiguation (via description) batch_69ef51fe3824819099f440426d3e6888 completed April 27, 2026, 12:09 p.m.
Created at: April 8, 2026, 9:40 p.m.